Literature DB >> 10101230

Caspase inhibitors block the retinal ganglion cell death following optic nerve transection.

P Chaudhary1, F Ahmed, P Quebada, S C Sharma.   

Abstract

Retinal ganglion cells die by apoptosis following axotomy. The molecular mechanisms of the retinal ganglion cell death are not well understood. In the present study using RT-PCR and in situ hybridization techniques we demonstrated that levels of mRNA for Bcl-2 and Bcl-x decreased after axotomy. Bax levels remained high until 4 days after axotomy, decreased by day 7 and remained low up to day 10. CPP32 levels increased at day 7 and remained high after optic nerve cut. We studied whether inhibitors of CPP32/caspase would save the axotomy induced ganglion cell death. DEVD-CHO (Ac-Asp-Glu-Val-aspartic acid aldehyde) and DEVD-FMK (Z-Asp-Glu-Val-Asp-FMK), caspase inhibitors, when administered intraocularly at the time of optic nerve cut, at days 3 and 7 protect about 30-35% the ganglion cells from death. We further demonstrated that the number of reactive microglia decrease in the retina when the inhibitors were given as compared with retina where no inhibitors were given. The present data offers new avenues for studying the complex interactions between the retinal ganglion cell death and the activation of resident microglia/macrophages. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101230     DOI: 10.1016/s0169-328x(99)00032-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  22 in total

1.  Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases.

Authors:  J T Finn; M Weil; F Archer; R Siman; A Srinivasan; M C Raff
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

2.  Apoptotic cell death and microglial cell responses in cultured rat retina.

Authors:  Karl Engelsberg; Berndt Ehinger; Johan Wassélius; Kjell Johansson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-27       Impact factor: 3.117

3.  Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.

Authors:  Vasanthy Vigneswara; Nsikan Akpan; Martin Berry; Ann Logan; Carol M Troy; Zubair Ahmed
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

4.  Critical interval of somal calcium transient after neurite transection determines B 104 cell survival.

Authors:  Michael P Nguyen; George D Bittner; Harvey M Fishman
Journal:  J Neurosci Res       Date:  2005-09-15       Impact factor: 4.164

Review 5.  Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.

Authors:  Karine Evangelho; Maria Mogilevskaya; Monica Losada-Barragan; Jeinny Karina Vargas-Sanchez
Journal:  Int Ophthalmol       Date:  2017-12-30       Impact factor: 2.031

6.  Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells.

Authors:  Frank Schuettauf; David Zurakowski; Kristine Quinto; Meghana A Varde; Dorothea Besch; Alan Laties; Ralph Anderson; Rong Wen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 7.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

Review 8.  Mechanisms of retinal ganglion cell injury and defense in glaucoma.

Authors:  Juan Qu; Danyi Wang; Cynthia L Grosskreutz
Journal:  Exp Eye Res       Date:  2010-04-13       Impact factor: 3.467

9.  Death and neuroprotection of retinal ganglion cells after different types of injury.

Authors:  M Vidal-Sanz; M Lafuente; P Sobrado-Calvo; I Selles-Navarro; E Rodriguez; S Mayor-Torroglosa; M P Villegas-Perez
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 10.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.